Business Insights, Feb 2010, Pages: 137
to avoid these common pitfalls with case studies that illustrate best practices.
Key features of this report
- Discussion of the factors leading to current imperatives to increased biotech tech transfer
Cutting Edge Information, May 2009, Pages: 104
in primary investigator compensation, by phase
--Average compensation for Phase 1 (and Phase 2, 3, and 4) primary investigators based on years of experience Executive Summary
- Study Methodology
- Study
Cutting Edge Information, Sep 2009, Pages: 219
ROI. Our data benchmarks - developed from input from marketing executives, brand managers, speaker programs directors among others - will anchor your decisions. The report will help you build a clear
Cutting Edge Information, Jan 2011, Pages +: 181
- - Professional Healthcare Educator
- - Dietician
Appendices: Fair-Market Value Compensation Benchmarks
The four appendices in this report provide tabular data on fair-market value payments for thought leaders
Cutting Edge Information, Dec 2007, Pages: 151
enough to implement immediately.
Compare real-world sales investment levels and learn how industry leaders manage emerging trends. Our report gives you support for your ideas and helps you prepare
Cutting Edge Information, April 2010, Pages: 288
measurement tools, structure, staffing and budgets. Throughout the report, data are frequently broken out by company type, large, mid-sized, small, medical device or biotech. When possible, the report also
Cutting Edge Information, April 2009, Pages: 141
- Maximizing Sales Rep Success
Structures, Budgets and Sales Staff Compensation
- Sales Force Contraction Data
- Sales Force Investments
- Sales Staff CompensationExecutive Summary
LIST OF FIGURES
Datamonitor, Dec 2010, Pages: 128
.
- Assess the contrasting growth dynamics forecast across PharmaVitae's Big Pharma, Mid-Pharma, Biotech and Japan Pharma peer sets.
Highlights
- Over 2003–09, the PharmaVitae Universe—comprised
Cutting Edge Information, Oct 2011, Pages: 128
The latest report from Cutting Edge Information will enable readers to develop HOL capabilities and reach payers via optimal team alignment and structure, competitive compensation and a strong slate
Decision Resources, Inc., Nov 2007, Pages: 32
operations to CROs in China and India. A wide array of factors, however, can dictate whether such a move is successful; in this report, we examine the myriad potential savings and costs that can contribute
Espicom Business Intelligence Ltd, June 2010, Pages: 70
. Lundbeck will actively seek new partnership agreements in order to compensate for its limited size and financial resources. They also allow Lundbeck to tap into competencies and know-how which may
MRI Limited (Meta Reports), Nov 2008, Pages: 312
. Despite no sign of success in any of the dozens of clinical trials already reported, we account for more than 80 companies in pursuit of the promised heart mender. Such a scale of drug development
John Wiley and Sons Ltd, July 2010, Pages: 1024
, Oil and Gas Exploration, Financial Planning with Simulation, Hospital Risk Management, Risk-Based ExecutiveCompensation Valuation, and Risk-Based Schedule Planning
Case Study: Pharmaceutical
Jain PharmaBiotech, Feb 2012, Pages: 639
in the report.The report is supplemented with 58 tables and 8 figures. Executive Summary
1. Introduction to cancer therapy
Molecular biology of cancer
The genesis of cancer
Normal cell cycle and growth
Plunkett Research, Ltd, Nov 2011, Pages: 714
Provided: 38
- Companies Profiled: 476
- Geographic Focus: Global
A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms
Business Monitor International, Feb 2010, Pages: 67
subsidised low-grade rice and compensating the poor with vouchers. The policy aimed to remove subsidised ST-15 rice from sale immediately and begin the new programme in December. Problems with the distribution
VC Experts, Jan 2009
Additional Shares)
6.10.1.c: Stock Purchase Agreement for Conceptus, Inc.
7.1.1: Compensation Generally
7.1.1.a: Securing the Key Employees
7.1.1.b: Commentary: Getting Creative with Executive
CYGNUS Business Consulting & Research, March 2008, Pages: 143
will not be feasible unless the demand can compensate for the low margins. Global vaccines market is estimated at USD10 billion in 2007; human vaccine valued at USD8.3 billion contributes major share ie 83% of the total
Jain PharmaBiotech, Feb 2012, Pages: 659
the therapeutic applications. This report takes broad overview of gene therapy and is the most up-to-date presentation from the author on this topic built-up from a series of gene therapy report written by him
Datamonitor, Nov 2010, Pages: 244
R&D and manufacturing
M&A activity
7. China - Bibliography
China - Executive summary
Publications and online articles
Datamonitor reports and products
China - Socio-demographic and Economic
